Heparin-Binding Domains in Vascular Biology
- 1 September 2004
- journal article
- review article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 24 (9) , 1549-1557
- https://doi.org/10.1161/01.atv.0000137189.22999.3f
Abstract
Heparin is a major anticoagulant with activity mediated primarily through its interaction with antithrombin (AT). Heparan sulfate (HS), structurally related to heparin, binds a wide range of proteins of different functionality, taking part in various physiological and pathological processes. The heparin–AT complex, the most well understood facet of anticoagulation, serves as a prototypical example of the important role of heparin/HS in vascular biology. Extensive studies have identified common structural features in heparin/HS–binding sites of proteins. These include the elucidation of consensus sequences in proteins, patterns of clusters of basic and nonbasic residues, and common spatial arrangements of basic amino acids in the heparin-binding sites. Although these studies have provided valuable information, heparin/HS–binding proteins differ widely in structure. The prediction of heparin/HS–binding proteins from sequence information is not currently possible, and elucidation of protein-binding sites req... Heparin and structurally related heparan sulfate bind a large number of proteins, taking part in a wide range of biological processes, particularly ones involved in vascular biology. Heparin-binding domains share certain common structural features, but there is no absolute dependency on specific sequences or protein folds.Keywords
This publication has 111 references indexed in Scilit:
- Order out of complexity – protein structures that interact with heparinCurrent Opinion in Structural Biology, 2001
- Structural and Energetic Characteristics of the Heparin-binding Site in Antithrombotic Protein CPublished by Elsevier ,2001
- Heparin-binding Growth-associated Molecule Contains Two Heparin-binding β-Sheet Domains That Are Homologous to the Thrombospondin Type I RepeatJournal of Biological Chemistry, 2000
- Site-Directed Mutagenesis and Molecular Modeling Identify a Crucial Amino Acid in Specifying the Heparin Affinity of FGF-1Biochemistry, 1999
- The 2.6 Å structure of antithrombin indicates a conformational change at the heparin binding site 1 1Edited by R. HuberJournal of Molecular Biology, 1997
- Mechanism of Heparin Activation of Antithrombin. Evidence for Reactive Center Loop Preinsertion with Expulsion upon Heparin BindingBiochemistry, 1996
- Therapeutic uses of heparin beyond its traditional role as an anticoagulantTrends in Pharmacological Sciences, 1995
- Dermatan sulfate as a potential therapeutic agentGeneral Pharmacology: The Vascular System, 1995
- Heparinlike molecules with anticoagulant activity are synthesized by cultured endothelial cellsBiochemical and Biophysical Research Communications, 1985
- Hard and Soft Acids and BasesJournal of the American Chemical Society, 1963